Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

ClinicalTrials.gov ID: NCT05179057

Public ClinicalTrials.gov record NCT05179057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 2:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial, With Cross-Over, of Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of Posoleucel for the treatment of adenovirus (AdV) infection in pediatric and adult allo-HCT recipients receiving standard of care (SoC).

Study identification

NCT ID
NCT05179057
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AlloVir
Industry
Enrollment
57 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2022 (Actual)
Primary completion
Jan 31, 2024 (Actual)
Completion
Jan 31, 2024 (Actual)
Last update posted
May 8, 2024

2022 – 2024

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
MD Anderson Cancer Center Gilbert Arizona 85234 —
Phoenix Children's Hospital Phoenix Arizona 85016 —
City of Hope Duarte California 91010 —
University of California, Los Angeles (UCLA) Los Angeles California 90095 —
Lucile Packard Children's Hospital - Stanford University Palo Alto California 94303 —
University of California, San Diego - Rady Children's Hospital San Diego California 92123 —
Children's Hospital Colorado - Center for Cancer and Blood Disorders Aurora Colorado 80045 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
University of Florida (UF) - Gainesville Gainesville Florida 32611 —
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
University of Minnesota Minneapolis Minnesota 55455 —
Washington University School of Medicine in St. Louis St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
New York Presbyterian Hospital New York New York 10032 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Duke University Medical Center Durham North Carolina 27710 —
Cleveland Clinic Cleveland Ohio 44195 —
University of Oklahoma Oklahoma City Oklahoma 73104 —
University of Texas Southwestern Dallas Texas 75390 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Intermountain HealthCare - Primary Children's Hospital Salt Lake City Utah 81432 —
Seattle Children's Hospital Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05179057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2024 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05179057 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →